Free tool
Oncology stocks
We cover 123 companies grouped under the Oncology theme. The median market value in the group is $27.54M. Across the group, the median move over the past trading day is +0.02%. 28% of the 120 with a 200-day average trade above it. Price change over the past year runs from −81.3% to +38.8% across the middle 80 percent of the group, with a median of −37.7%. Across the group, 1 company currently carries a tier A volume signal.
Other lists in this group
SaaSAI applicationsCybersecuritySemiconductor designSemiconductor equipmentFintech softwarePayment processingEcommerce marketplacesStreaming mediaGaming softwareOncologyRare diseaseMedical devicesCell therapyDiagnosticsRegional banksAsset managementGold miningCryptocurrency and digital assetsSpecialty chemicalsAll stocks
Table
123 of 319 companies match these filters.Clear filters
| Ticker | Company | Market cap (USD) | Size | 1Y return |
|---|---|---|---|---|
| BMY | Bristol-Myers Squibb Company | $138.74B | Large cap | +49.31% |
| 4519.T | Chugai Pharmaceutical Co., Ltd. | $73.00B | Large cap | +12.47% |
| RVMD | Revolution Medicines, Inc. | $45.35B | Large cap | +492.60% |
| 4568.T | Daiichi Sankyo Company, Limited | $33.36B | Large cap | −15.95% |
| INCY | Incyte Corporation | $26.29B | Large cap | +53.04% |
| GE9.DE | GENMAB AS N | $21.11B | Large cap | −14.41% |
| IPN.PA | Ipsen S.A. | $16.01B | Large cap | +39.21% |
| EXEL | Exelixis, Inc. | $14.05B | Large cap | +49.66% |
| 0IJO.L | Exelixis, Inc. | $14.05B | Large cap | +44.33% |
| SMMT | Summit Therapeutics Inc. | $10.66B | Large cap | −49.14% |
| JATT | JATT II Acquisition Corp. | $97.15M | Micro cap | +18.62% |
| 4575.T | CanBas Co., Ltd. | $96.08M | Micro cap | −40.51% |
| ACRV | Acrivon Therapeutics, Inc. | $93.42M | Micro cap | +63.91% |
| 4579.T | RaQualia Pharma Inc. | $93.23M | Micro cap | +4.58% |
| OSE.PA | OSE Immunotherapeutics SA | $88.77M | Micro cap | −47.82% |
| MAIA | MAIA Biotechnology, Inc. | $85.78M | Micro cap | −10.76% |
| CTOR | Citius Oncology, Inc. | $85.68M | Micro cap | −57.14% |
| 0QW5.L | Heidelberg Pharma AG | $84.14M | Micro cap | −45.58% |
| VRCA | Verrica Pharmaceuticals Inc. | $83.66M | Micro cap | −17.53% |
| 0J4V.L | Heron Therapeutics, Inc. | $82.85M | Micro cap | −76.73% |
| POLB.L | Poolbeg Pharma PLC | $82.75M | Micro cap | +161.54% |
| 4888.T | Stella Pharma Corporation | $82.15M | Micro cap | −9.23% |
| CRDF | Cardiff Oncology, Inc. | $79.35M | Micro cap | −53.85% |
| ELTX | Elicio Therapeutics, Inc. | $79.11M | Micro cap | −72.71% |
| OSTX | OS Therapies Incorporated | $76.68M | Micro cap | −24.66% |
| PLRX | Pliant Therapeutics, Inc. | $73.69M | Micro cap | −23.49% |
| XBIT | XBiotech Inc. | $70.43M | Micro cap | −28.13% |
| PMVP | PMV Pharmaceuticals, Inc. | $69.76M | Micro cap | −8.10% |
| BOLD | Boundless Bio, Inc. | $67.33M | Micro cap | +160.18% |
| MAAT.PA | MaaT Pharma SA | $66.80M | Micro cap | −39.58% |
| RNXT | RenovoRx, Inc. | $64.08M | Micro cap | +58.13% |
| HRTX | Heron Therapeutics, Inc. | $61.34M | Micro cap | −76.59% |
| XLO | Xilio Therapeutics, Inc. | $59.75M | Micro cap | −7.35% |
| IMM.AX | Immutep Limited | $57.02M | Micro cap | −77.96% |
| ATX.AX | Amplia Therapeutics Limited | $56.97M | Micro cap | −13.53% |
| IMMP | Immutep Limited | $56.28M | Micro cap | −77.54% |
| 0OCQ.L | Transgene SA | $55.45M | Micro cap | −18.38% |
| COIL.L | Coiled Therapeutics plc | $55.33M | Micro cap | −26.92% |
| 4564.T | OncoTherapy Science, Inc. | $53.87M | Micro cap | −25.00% |
| 0RAD.L | OSE Immunotherapeutics SA | $51.87M | Micro cap | −48.92% |
| TIL | Instil Bio, Inc. | $51.54M | Micro cap | −69.62% |
| 4597.T | Solasia Pharma K.K. | $51.47M | Micro cap | −23.68% |
| PTX.AX | Prescient Therapeutics Limited | $50.48M | Micro cap | +58.14% |
| CANTA.ST | Cantargia AB (publ) | $50.23M | Micro cap | −28.93% |
| IBO | Impact BioMedical Inc. | $49.62M | Micro cap | −20.79% |
| BKHA | Black Hawk Acquisition Corporation | $49.39M | Micro cap | +8.09% |
| SVE.WA | Synthaverse S.A. | $47.84M | Micro cap | −37.70% |
| 4594.T | BrightPath Biotherapeutics Co., Ltd. | $46.25M | Micro cap | −33.75% |
| MOC.WA | Molecure S.A. | $41.14M | Micro cap | −21.18% |
| CNTX | Context Therapeutics Inc. | $40.00M | Micro cap | −50.13% |
| 206A.T | PRISM BioLab Co.,LTD | $39.48M | Micro cap | −6.56% |
| SNT.AX | Syntara Limited | $36.57M | Micro cap | −1.89% |
| 190A.T | CHORDIA THERAPEUTICS INC | $34.51M | Micro cap | −58.56% |
| ATNM | Actinium Pharmaceuticals, Inc. | $33.88M | Micro cap | −39.66% |
| BCTX | BriaCell Therapeutics Corp. | $32.80M | Micro cap | −49.67% |
| BCT.TO | BriaCell Therapeutics Corp. | $32.32M | Micro cap | −50.62% |
| 4582.T | SymBio Pharmaceuticals Limited | $31.73M | Micro cap | −58.28% |
| BYSI | BeyondSpring Inc. | $29.61M | Micro cap | −60.43% |
| MDNA.TO | Medicenna Therapeutics Corp. | $29.00M | Micro cap | −58.77% |
| EVAX | Evaxion A/S | $28.36M | Micro cap | +4.49% |
| LTRN | Lantern Pharma Inc. | $27.87M | Micro cap | −52.30% |
| NNG.WA | NanoGroup S.A. | $27.54M | Micro cap | −14.09% |
| NXTC | NextCure, Inc. | $27.05M | Micro cap | +13.33% |
| PSTV | Plus Therapeutics Inc | $26.64M | Micro cap | −68.67% |
| ATOS | Atossa Therapeutics, Inc. | $26.35M | Micro cap | −76.49% |
| CVM | CEL-SCI Corporation | $26.03M | Micro cap | −85.98% |
| MRKR | Marker Therapeutics, Inc. | $25.34M | Micro cap | +20.63% |
| CLRB | Cellectar Biosciences, Inc. | $24.01M | Micro cap | −45.96% |
| CCM | Concord Medical Services Holdings Limited | $21.49M | Micro cap | −10.65% |
| ABVC | ABVC BioPharma, Inc. | $21.32M | Micro cap | −72.70% |
| ALLR | Allarity Therapeutics, Inc. | $21.16M | Micro cap | +41.34% |
| NOX.AX | Noxopharm Limited | $20.25M | Micro cap | −20.00% |
| DEX.ST | DexTech Medical AB | $20.14M | Micro cap | +20.93% |
| TPST | Tempest Therapeutics, Inc. | $18.36M | Micro cap | −89.50% |
| B8FK.DE | Biofrontera AG | $17.95M | Micro cap | −4.55% |
| ABERA.ST | Abera Bioscience AB | $17.74M | Micro cap | −0.12% |
| 4882.T | Perseus Proteomics Inc. | $17.25M | Micro cap | −56.43% |
| RAD.AX | Radiopharm Theranostics Limited | $16.95M | Micro cap | −62.96% |
| CTXR | Citius Pharmaceuticals, Inc. | $16.57M | Micro cap | −52.09% |
| MDCX | Medicus Pharma Ltd. | $16.26M | Micro cap | −87.97% |
| INTS | Intensity Therapeutics, Inc. | $15.98M | Micro cap | −37.24% |
| LSTA | Lisata Therapeutics, Inc. | $15.68M | Micro cap | −31.23% |
| ACTI.ST | Active Biotech AB (publ) | $15.34M | Micro cap | −60.62% |
| AKTX | Akari Therapeutics, Plc | $14.54M | Micro cap | −77.77% |
| PHIO | Phio Pharmaceuticals Corp. | $13.82M | Micro cap | −41.21% |
| GTBP | GT Biopharma, Inc. | $13.52M | Micro cap | −72.50% |
| BLRX | BioLineRx Ltd. | $12.45M | Micro cap | −25.97% |
| TOVX | Theriva Biologics, Inc. | $10.90M | Micro cap | −45.33% |
| LNAI | Lunai Bioworks Inc. | $9.97M | Micro cap | −87.99% |
| PUR.WA | MultiQure S.A. | $9.74M | Micro cap | −53.66% |
| 4598.T | Delta-Fly Pharma, Inc. | $9.30M | Micro cap | −81.94% |
| IMNN | Imunon, Inc. | $8.92M | Micro cap | −73.86% |
| CNSP | CNS Pharmaceuticals, Inc. | $8.48M | Micro cap | −11.31% |
| AIM | AIM ImmunoTech Inc. | $7.73M | Micro cap | −89.97% |
| PAB.AX | Patrys Limited | $7.53M | Micro cap | −11.43% |
| BOLT | Bolt Biotherapeutics, Inc. | $7.42M | Micro cap | −29.28% |
| CANF | Can-Fite BioPharma Ltd. | $7.11M | Micro cap | −74.46% |
| ALOPM.PA | Oncodesign Precision Medicine Société anonyme | $7.10M | Micro cap | −17.01% |
| CHOSA.ST | CHOSA Oncology AB | $7.04M | Micro cap | −12.00% |
| ITOC | iTonic Holdings Ltd. | $6.75M | Micro cap | −51.75% |
| LIMN | Liminatus Pharma, Inc. | $6.19M | Micro cap | +35.59% |
| NCNA | NuCana plc | $6.12M | Micro cap | −56.76% |
| PCSA | Processa Pharmaceuticals, Inc. | $6.09M | Micro cap | −60.36% |
| KAPA | Kairos Pharma, Ltd. | $5.88M | Micro cap | −79.82% |
| 0GP7.L | Medivir AB (publ) | $5.78M | Micro cap | +3.85% |
| NFX.L | Nuformix plc | $5.64M | Micro cap | +106.25% |
| PER.AX | PERCHERON FPO [PER] | $5.45M | Micro cap | −54.55% |
| BCAB | BioAtla, Inc. | $5.43M | Micro cap | −81.69% |
| HCWB | HCW Biologics Inc. | $4.77M | Micro cap | −53.15% |
| APS.TO | Aptose Biosciences Inc | $4.42M | Micro cap | +37.14% |
| OSRH | OSR Health, Inc. | $4.09M | Micro cap | −88.47% |
| DBP-B.ST | Double Bond Pharmaceutical Int. | $3.69M | Micro cap | +9.33% |
| RDHL | RedHill Biopharma Ltd. | $3.68M | Micro cap | −55.83% |
| CLDI | Calidi Biotherapeutics, Inc. | $3.39M | Micro cap | −16.03% |
| GOVX | GeoVax Labs, Inc. | $3.34M | Micro cap | −96.61% |
| ARTL | Artelo Biosciences, Inc. | $3.30M | Micro cap | −97.47% |
| IVX.AX | Invion Limited | $2.90M | Micro cap | −70.00% |
| VAL.L | ValiRx plc | $2.79M | Micro cap | −73.04% |
| NXTS | Nexentis Technologies Inc. | $2.69M | Micro cap | −96.64% |
| PPBT | Purple Biotech Ltd | $2.68M | Micro cap | −92.53% |
| PPCB | Propanc Biopharma, Inc. | $2.57M | Micro cap | −98.66% |
| NX1.AX | Nexalis Therapeutics Limited | $1.99M | Micro cap | −50.00% |
| PTP.DE | Pentixapharm Holding AG N | $1.08M | Micro cap | +8.55% |
Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.